#VisualAbstract: High-Dose Recombinant Influenza Vaccine is

#VisualAbstract: High-Dose Recombinant Influenza Vaccine is More Effective than Standard-Dose Vaccine in Adults Aged 50 to 64 Years

Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Related Keywords

, Minute Medicine Inc , Egg Based Vaccine , Flu Vaccine , Influenza , Influenza A , Influenza B , Quadrivalent Vaccine , Recombinant Vaccine , Vaccination , Vaccine , Vaccine Dose , Vaccine Effectiveness , Studygraphics ,